Neurogene (Neurogene) Current Accrued Expense : $4.73 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Neurogene Current Accrued Expense?

Neurogene's Current Accrued Expense for the quarter that ended in Mar. 2024 was $4.73 Mil.

Neurogene's quarterly Current Accrued Expense increased from Sep. 2023 ($2.62 Mil) to Dec. 2023 ($10.79 Mil) but then declined from Dec. 2023 ($10.79 Mil) to Mar. 2024 ($4.73 Mil).

Neurogene's annual Current Accrued Expense increased from Dec. 2021 ($1.33 Mil) to Dec. 2022 ($1.80 Mil) and increased from Dec. 2022 ($1.80 Mil) to Dec. 2023 ($10.79 Mil).

Neurogene Current Accrued Expense Historical Data

The historical data trend for Neurogene's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Current Accrued Expense Chart

Neurogene Annual Data

Trend

Dec21

Dec22

Dec23

Current Accrued Expense

1.33

1.80

10.79

Neurogene Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial			-	2.10	2.62	10.79	4.73

Neurogene Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Neurogene Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Neurogene's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurogene (Neurogene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

535 W 24th Street, 5th Floor, New York, NY, USA, 10011

Website

https://www.neurogene.com

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines

From GuruFocus

Neurogene Announces Business Update and 2024 Outlook

By Business Wire • 01-05-2024

Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

By Business Wire • 12-19-2023